Barrett's esophagus (BE) is a common condition associated with chronic gastroesophageal
reflux disease. BE is the only known precursor to esophageal adenocarcinoma, a highly …

Esophageal cancer is a serious malignancy with high mortality. The two common distinctive
pathologic subtypes of esophageal cancer are squamous cell carcinoma and …

Background and Aims Seattle protocol forceps biopsy sampling (FB) is currently
recommended for surveillance in Barrett's esophagus (BE) but limited by sampling error and …

METHODS: BE cases had≥ 1 cm of circumferential BE with intestinal metaplasia; controls
had no endoscopic evidence of BE. The SOS device was withdrawn 8 minutes after …

Background and Aims After endoscopic resection (ER) of early esophageal
adenocarcinoma (EAC), the optimal management of patients with high-risk histologic …

Background and Aims The treatment of submucosal (T1b) esophageal adenocarcinoma
(EAC) remains in evolution, with some evidence supporting endoscopic management of low …

Despite substantial efforts at early diagnosis, accurate staging and advanced treatments,
esophageal cancer (EC) continues to be an ominous disease worldwide. Risk factors for …

Endoscopic surveillance of Barrett's esophagus, aiming to detect prevalent dysplasia and
adenocarcinoma, followed by effective endoscopic treatment, is an integral part of the …

Background The development of tumor cells inside the lymphatics or blood vessels is known
as lymphovascular invasion (LVI). The correlation between LVI, lymph node metastasis …

METHODS: Patients who underwent EET for T1a EAC at 3 referral Barrett's esophagus
endotherapy units between 1996 and 2022 were included. Patients with submucosal …